Literature DB >> 29766592

Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.

Jacob A Lebin1, David L Murphy1, Stevan Geoffrey Severtson2, Gabrielle E Bau2, Nabarun Dasgupta2, Richard C Dart2,3.   

Abstract

PURPOSE: Diverted prescription opioids are significant contributors to drug overdose mortality. Street price has been suggested as an economic metric of the diverted prescription opioid black market. This study examined variables that may influence the street price of diverted oxycodone and oxymorphone.
METHODS: A cross-sectional study was conducted utilizing data from the previously validated, crowdsourcing website StreetRx. Street price reports of selected oxycodone and oxymorphone products, between August 22, 2014 and June 30, 2016, were considered for analysis. Geometric means and 95% confidence intervals were calculated comparing prices per milligram of drug in US dollars. Univariate and multivariable regressions were used to examine the influence of dosage strength, drug formulation, and bulk purchasing on street price.
RESULTS: A total of 5611 oxycodone and 1420 oxymorphone reports were analyzed. Across various dosages and formulations, geometric mean prices per milligram ranged between $0.12 and $1.07 for oxycodone and $0.73 and $2.90 for oxymorphone. For a 2-fold increase in dosage strength, there is a 24.0% (95% CI: -28.1%, -19.6%, P < 0.001) and a 22.5% (95% CI: -24.2%, -20.8%, P < 0.001) decrease on average in price per milligram for oxycodone and oxymorphone, respectively. Lower potency, high dosage strength, crush-resistant opioids, and those purchased in bulk were significantly cheaper.
CONCLUSION: Street prices for diverted oxycodone and oxymorphone are influenced by multiple factors including potency, dosage, formulation, and bulk purchasing. Buyers who purchase large quantities of low potency, large dosage, crush-resistant formulation prescription opioids can expect to achieve the lowest price.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  RADARS system; drug abuse; drug diversion; pharmacoepidemiology; prescription opioids; quantity discounts; street price

Mesh:

Substances:

Year:  2018        PMID: 29766592     DOI: 10.1002/pds.4558

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017.

Authors:  Kirsten Elin Smith; Adrian Archuleta; Michele Staton; Erin Winston
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-03       Impact factor: 3.829

2.  Opioid losses in terms of dosage and value, January 2012 to September 2017: a retrospective analysis of Health Canada data.

Authors:  Mark Fan; Dorothy Tscheng; Michael Hamilton; Patricia Trbovich
Journal:  CMAJ Open       Date:  2020-02-24

3.  Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomes.

Authors:  Shanna Babalonis; Sandra D Comer; Jermaine D Jones; Paul Nuzzo; Michelle R Lofwall; Jeanne Manubay; Kevin W Hatton; Robert A Whittington; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2021-06-01       Impact factor: 4.415

4.  Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study.

Authors:  Joshua Black; Zachary R Margolin; Gabrielle Bau; Richard Olson; Janetta L Iwanicki; Richard C Dart
Journal:  JMIR Public Health Surveill       Date:  2021-12-20

5.  Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER.

Authors:  Stevan Geoffrey Severtson; Scott E D Kreider; Elise C Amioka; Zachary R Margolin; Janetta L Iwanicki; Richard C Dart
Journal:  Pain Med       Date:  2020-12-25       Impact factor: 3.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.